Brimonidine/Timolol - TearClear
Alternative Names: TC-003Latest Information Update: 25 May 2023
At a glance
- Originator TearClear
- Class Antiglaucomas; Antihypertensives; Eye disorder therapies; Imidazoles; Morpholines; Propanolamines; Quinoxalines; Small molecules; Thiadiazoles
- Mechanism of Action Alpha 2 adrenergic receptor agonists; Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Glaucoma